Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rosario Hervas-Salcedo"'
Autor:
Rosario Hervas-Salcedo, Juan A. Bueren, María Fernández-García, Marina I. Garin, Mercedes Lopez-Santalla
Publikováno v:
Journal of Crohn's & Colitis
Background and Aims Mesenchymal stem cells [MSCs] are used in preclinical and clinical studies for treatment of immune-mediated disorders, thanks to their immunomodulatory properties. Cell therapy with MSCs induces multiple effects in the immune syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572565874fc6bcc6da7bc068030515f2
https://doi.org/10.1093/ecco-jcc/jjaa079
https://doi.org/10.1093/ecco-jcc/jjaa079
Autor:
Mariano García-Arranz, Juan A. Bueren, Miriam Hernando-Rodríguez, Jose-Carlos Segovia, Pablo Minguez, Rosa Yañez, Rosario Hervas-Salcedo, Damián García-Olmo, Marta Rodriguez de Alba, Victoria del Pozo, Carmen Ayuso, María L. Lamana, Oscar Quintana-Bustamante, María Fernández-García, Marcio Alvarez-Silva
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-20 (2021)
Stem Cell Research & Therapy
instname
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-20 (2021)
Stem Cell Research & Therapy
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Background Mesenchymal stromal cells (MSCs) constitute one of the cell types most frequently used in cell therapy. Although sev
Background Mesenchymal stromal cells (MSCs) constitute one of the cell types most frequently used in cell therapy. Although sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4671aa6ba1d2c04049f25b2ecb96b6f0
https://doi.org/10.1186/s13287-021-02193-0
https://doi.org/10.1186/s13287-021-02193-0
Autor:
Rosario Hervás-Salcedo, María Fernández-García, Miriam Hernando-Rodríguez, Cristian Suárez-Cabrera, Juan A. Bueren, Rosa M. Yáñez
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Previous clinical trials have shown that mesenchymal stromal cells (MSCs) can modulate graft versus host disease (GvHD) after allogeneic hematopoietic transplantation, although with variable efficacy. To improve the anti-GvHD effect of these cells, a
Externí odkaz:
https://doaj.org/article/581e71e1bf154dabbdb4561eeae3e254
Autor:
Rosario Hervás-Salcedo, María Fernández-García, Miriam Hernando-Rodríguez, Oscar Quintana-Bustamante, Jose-Carlos Segovia, Marcio Alvarez-Silva, Mariano García-Arranz, Pablo Minguez, Victoria del Pozo, Marta Rodríguez de Alba, Damián García-Olmo, Carmen Ayuso, María Luisa Lamana, Juan A. Bueren, Rosa María Yañez
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-20 (2021)
Abstract Background Mesenchymal stromal cells (MSCs) constitute one of the cell types most frequently used in cell therapy. Although several studies have shown the efficacy of these cells to modulate inflammation in different animal models, the resul
Externí odkaz:
https://doaj.org/article/a4edfc5b4d534d57adac5f5bd188b1b0
Autor:
David García-Bernal, Mariano García-Arranz, Rosa M. Yáñez, Rosario Hervás-Salcedo, Alfonso Cortés, María Fernández-García, Miriam Hernando-Rodríguez, Óscar Quintana-Bustamante, Juan A. Bueren, Damián García-Olmo, Jose M. Moraleda, José C. Segovia, Agustín G. Zapata
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Mesenchymal stromal cells (MSCs) currently constitute the most frequently used cell type in advanced therapies with different purposes, most of which are related with inflammatory processes. Although the therapeutic efficacy of these cells has been c
Externí odkaz:
https://doaj.org/article/853ec33895be4f25a541038cf46a91dc